Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

TA Tummino, VV Rezelj, B Fischer, A Fischer… - Science, 2021 - science.org
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning …
被引用次数：171 相关文章
[HTML] nih.gov

[HTML][HTML] Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

TA Tummino, VV Rezelj, B Fischer, A Fischer… - Science (New York …, 2021 - ncbi.nlm.nih.gov
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning …

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

TA Tummino, VV Rezelj, B Fischer, A Fischer… - Science, 2021 - pasteur.hal.science
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning …

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

TA Tummino, VV Rezelj, B Fischer, A Fischer… - Science, 2021 - cir.nii.ac.jp
抄録< jats: title> Screening for drugs that don't work</jats: title>< jats: p> In the battle against
COVID-19, drugs discovered in repurposing screens are of particular interest because these …

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

T Tummino, V Rezelj, B Fischer, A Fischer, B Monel… - Science, 2021 - oak.novartis.com
Repurposing drugs as treatments for COVID-19 has drawn much attention. Beginning with
sigma receptor ligands, and expanding to other drugs from screening in the field, we …

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.

TA Tummino, VV Rezelj, B Fischer, A Fischer… - Science (New York …, 2021 - europepmc.org
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning …

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

TA Tummino, VV Rezelj, B Fischer… - … (New York, NY), 2021 - pubmed.ncbi.nlm.nih.gov
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning …

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

TA Tummino, VV Rezelj, B Fischer, A Fischer… - Science, 2021 - ui.adsabs.harvard.edu
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning …

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

TA Tummino, VV Rezelj, B Fischer, A Fischer… - Science, 2021 - escholarship.org
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning …

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

TA Tummino, VV Rezelj, B Fischer, A Fischer… - Science, 2021 - hal.science
Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning …